Risk-Based Monitoring
Monitoring strategy that targets oversight resources to the highest-risk sites, processes, and data based on a documented risk assessment, replacing 100% source data verification.
Definition
Risk-Based Monitoring (RBM) is a clinical trial oversight approach that uses a documented risk assessment to direct monitoring resources to the trial elements (sites, processes, data points) most critical to subject safety and data integrity. Rather than performing 100% source data verification (SDV) at every site, sponsors combine centralized statistical monitoring (off-site analytics on EDC data), targeted on-site monitoring focused on critical data and processes, and remote source data review where feasible. The broader practice, Risk-Based Quality Management (RBQM), extends this approach to all quality oversight activities.What this means in practice
RBM became the default expectation under ICH E6(R2) addendum (2016) and is reinforced in E6(R3) (2023). For device IDE studies, sponsors implementing RBM must produce a documented risk assessment, defined Key Risk Indicators (KRIs) and Quality Tolerance Limits (QTLs), trigger-based monitoring procedures, and centralized monitoring analytics. FDA bioresearch monitoring inspections increasingly evaluate RBM implementation depth.- •Declaring RBM without a documented risk assessment, the assessment is the foundation; without it, RBM is just reduced SDV.
- •Setting KRIs/QTLs without thresholds for action, KRIs that no one acts on add cost without benefit.
- •Cutting on-site visits to zero, RBM redistributes monitoring, it doesn't eliminate it.
Related terms
Shared paths + categoryGood clinical practice for clinical investigations of medical devices.
Independent committee that periodically reviews accumulating safety and (sometimes) efficacy data during a trial.
A trial that uses telehealth, home-based assessments, wearables, and direct-to-patient logistics to reduce or eliminate site visits.
Software systems used to collect, manage, and report clinical trial data electronically, replacing paper case report forms.
Process of comparing data in case report forms against original source records.
The collection of essential documents that demonstrates the conduct of a clinical trial complies with GCP and applicable regulatory requirements.
Latest in MedTech
Primary references
3 sources- 1FDA Oversight of Clinical Investigations GuidanceVerifiedFDAfda.gov
- 2ICH E6(R3) Good Clinical PracticeVerifiedICHich.org
- 3ClinicalTrials.govVerifiedNIHclinicaltrials.gov
Inline markers like [1] jump to the matching reference above.